Glutamine deficiency drives transforming growth factor‐β signaling activation that gives rise to myofibroblastic carcinoma‐associated fibroblasts
Yoshihiro Mezawa(Juntendo University), Akira Orimo(University of Manchester), Reo Maruyama(Brigham and Women's Hospital), Tomoyuki Yokose(Kanagawa Prefectural Hospital Organization), Liying Yang(Japanese Foundation For Cancer Research), Toshinari Yamashita(Kanagawa Prefectural Hospital Organization), Hiroyuki Seimiya(Japanese Foundation For Cancer Research), Yohei Miyagi(Kanagawa Cancer Center), Tingwei Wang(Juntendo University), Atsushi Takano(The University of Tokyo), Yataro Daigo(The University of Tokyo)
Cited by 12
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
|Nature Genetics|2000|950
HJURP Is a Cell-Cycle-Dependent Maintenance and Deposition Factor of CENP-A at Centromeres
|Cell|2009|636
Mutations truncating the EP300 acetylase in human cancers
|Nature Genetics|2000|593